FirstWord

The biotech's stock gained more than 66% on its first day of trading.

The patient died of septic pneumonia the day after receiving a high dose of chemotherapy, and 44 days after receiving an infusion of CD19-directed CAR-T cell therapy zolacabtagene autoleucel.

The trio will work together to design adaptive clinical trials for Alzheimer's disease and other neurological conditions.

The BTK inhibitor's Phase III efficacy results lag Roche's fenebrutinib, though its favourable liver safety profile could strengthen the drug's appeal.

Detailed Phase III findings showed a 3.3-month median overall survival advantage for CLDN18.2-targeted antibody-drug conjugate (ADC) arcotatug tavatecan.

Published: 23 Oct 2026Latest phase III data show no improvement in event-free survival with the addition of peri-operative durvalumab to standard therapyPractice-changing results from the NIAGARA tria...

Published: 23 Oct 2026Findings from the TALENT trial, the first neoadjuvant study of an antibody–drug conjugate therapy in HR-positive, HER2-low early breast cancer, are soberingTrastuzumab deruxtecan...

Published: 23 Oct 2026The STARBOARD study supports treatment intensification and reports a predictable safety profile for the combinationFinal analysis results of the STARBOARD trial have demonstrated...

Published: 23 Oct 2026GERCOR-GONO DEWI study results are promising in localised dMMR/MSI-H disease, but response definition and the optimal duration of immunotherapy in responding patients need to be ...

First-in-human data for ARR-217 selected as a late-breaking oral presentation ArriVent to host virtual webinar on Monday, October 26, 2026, at 8 am ET to discuss the data from the ARR-217 programNEWTO...